Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study-Reference-Cited by-同舟云学术

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

Published:2020-01-01 Issue:2 Volume:48 Page:249-258
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Floridia Marco^ORCID, ,Dalzero Serena,Giacomet Vania,Tamburrini Enrica,Masuelli Giulia,Savasi Valeria,Spinillo Arsenio,Tassis Beatrice,Franceschetti Laura,Degli Antoni Anna Maria,Sansone Matilde,Guaraldi Giovanni,Vimercati Antonella,Meloni Alessandra,Ravizza Marina

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s15010-019-01384-5.pdf

Reference22 articles.

1. Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. https://aidsinfo.nih.gov/guidelines. Accessed June 27 2019.

2. British HIV association. BHIVA guidelines on the management of HIV in pregnancy and postpartum 2018 (2019 interim update). https://www.bhiva.org/pregnancy-guidelines. Accessed June 27 2019.

3. Linee Guida Italiane sull’utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1. http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=3283. Accessed June 27 2019.

4. Mandelbrot L, Tubiana R, Le Chenadec J, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;61:1715–25.

5. Uthman OA, Nachega JB, Anderson J, et al. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. Lancet HIV. 2017;4:e21–30.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis;Frontiers in Medicine;2024-02-27

2. Maternal antiretroviral treatment for HIV infection and risk of small-for-gestational-age birth: A systematic review and meta-analysis of protease inhibitor-based treatment and timing of treatment;International Journal of Antimicrobial Agents;2023-07

3. Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV;AIDS;2023-05-23

4. Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China;Frontiers in Medicine;2023-05-18

5. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis;BMC Pregnancy and Childbirth;2023-01-30